CAGR (Compound Annual Growth Rate) is a financial term that evaluates an investment’s yearly growth rate over a given time period. It smoothes growth and adjusts for compounding effects. CAGR is commonly used to assess corporate performance and investment returns, offering insight into long-term trends.
Here are the 3 stocks with net profit CAGR of up to 47 percent in 3 years:
Cipla Ltd
Cipla Limited’s primary business is medicines. The company operates in two segments: pharmaceuticals and new ventures. The Pharmaceuticals division develops, manufactures, sells, and distributes generic and branded pharmaceuticals, as well as API.
With a market capitalization of Rs 1.26 lakh crore, the shares closed at Rs 1,568.10 per share, decreased around 1 percent as compared to the previous closing price.
The company’s consolidated net profit numbers have showcased an increase from Rs 2,389 crores during FY21-22 to Rs 4,154 crores in FY23-24. The company has a net profit CAGR for 3 years is 22 Percent.
Zydus Lifesciences Ltd
Zydus Lifesciences Ltd. manufactures, markets, and sells finished dosage human formulations, including generics, biosimilars, vaccines, active pharmaceutical ingredients (APIs), animal healthcare products, and consumer wellness products.
With a market capitalization of Rs 1.17 lakh crore, the shares closed at Rs 1,164.20 per share, decreased around 1 percent as compared to the previous closing price.
The company’s consolidated net profit numbers have showcased an increase from Rs 2,185 crores during FY21-22 to Rs 3,973 crores in FY23-24. The company has a net profit CAGR for 3 years is 22 Percent.
Natco Pharma Ltd
Natco Pharma Limited is a vertically integrated pharmaceutical firm located in India with an emphasis on R&D. The Company’s pharmaceutical business includes R&D, manufacture, and sales of bulk medications and final dosage formulations.
With a market capitalization of Rs 26,303.18 crore, the shares were trading at Rs 1,452.25 per share, decreasing around 1.58 percent as compared to the previous closing price.
The company’s consolidated net profit numbers have showcased an increase from Rs 442 crores during FY21-22 to Rs 1,388 crores in FY23-24. The company has a net profit CAGR for 3 years is 47 Percent.
Written by:- Abhishek Singh
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
